Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension. The COVID-19 pandemic has altered routine standard of care practice and the acute management particularly for those patients with pulmonary arterial hypertension, where pulmonary arterial hype...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-04-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894020920153 |
id |
doaj-b034bf03d51a49d39b094a121c23e8ac |
---|---|
record_format |
Article |
spelling |
doaj-b034bf03d51a49d39b094a121c23e8ac2020-11-25T03:35:23ZengSAGE PublishingPulmonary Circulation2045-89402020-04-011010.1177/2045894020920153Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemicJohn J. Ryan0Lana Melendres-Groves1Roham T. Zamanian2Ronald J. Oudiz3Murali Chakinala4Erika B. Rosenzweig5Mardi Gomberg-Maitland6Division of Cardiovascular Medicine, University of Utah, Salt Lake City, UT, USADivision of Pulmonary and Critical Care Medicine, University of New Mexico, Albuquerque, NM, USADivision of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, USADivision of Cardiology, Lundquist Institute for Biomedical Innovation & Research at Harbor–UCLA Medical Center, Torrance, CA, USADepartment of Medicine, Washington University School of Medicine, St. Louis, MO, USADivision of Pediatric Cardiology, Columbia University College of Physicians & Surgeons, New York, NY, USADivision of Cardiovascular Medicine, George Washington University Medicine and Health Sciences, Washington, DC, USAThe COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension. The COVID-19 pandemic has altered routine standard of care practice and the acute management particularly for those patients with pulmonary arterial hypertension, where pulmonary arterial hypertension-specific treatments are used. It is important to balance the ongoing care and evaluation of pulmonary arterial hypertension patients with “exposure risk” to COVID-19 for patients coming to clinic or the hospital. If there is a morbidity and mortality benefit from starting pulmonary arterial hypertension therapies, for example in a patient with high-likelihood of pulmonary arterial hypertension, then it remains important to complete the thorough evaluation. However, the COVID-19 outbreak may also represent a unique time when pulmonary hypertension experts have to weigh the risks and benefits of the diagnostic work-up including potential exposure to COVID-19 versus initiating targeted pulmonary arterial hypertension therapy in a select high-risk, high likelihood World Symposium Pulmonary Hypertension Group 1 pulmonary arterial hypertension patients. This document will highlight some of the issues facing providers, patients, and the pulmonary arterial hypertension community in real-time as the COVID-19 pandemic is evolving and is intended to share expected common clinical scenarios and best clinical practices to help the community at-large.https://doi.org/10.1177/2045894020920153 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
John J. Ryan Lana Melendres-Groves Roham T. Zamanian Ronald J. Oudiz Murali Chakinala Erika B. Rosenzweig Mardi Gomberg-Maitland |
spellingShingle |
John J. Ryan Lana Melendres-Groves Roham T. Zamanian Ronald J. Oudiz Murali Chakinala Erika B. Rosenzweig Mardi Gomberg-Maitland Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic Pulmonary Circulation |
author_facet |
John J. Ryan Lana Melendres-Groves Roham T. Zamanian Ronald J. Oudiz Murali Chakinala Erika B. Rosenzweig Mardi Gomberg-Maitland |
author_sort |
John J. Ryan |
title |
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic |
title_short |
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic |
title_full |
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic |
title_fullStr |
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic |
title_full_unstemmed |
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic |
title_sort |
care of patients with pulmonary arterial hypertension during the coronavirus (covid-19) pandemic |
publisher |
SAGE Publishing |
series |
Pulmonary Circulation |
issn |
2045-8940 |
publishDate |
2020-04-01 |
description |
The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension. The COVID-19 pandemic has altered routine standard of care practice and the acute management particularly for those patients with pulmonary arterial hypertension, where pulmonary arterial hypertension-specific treatments are used. It is important to balance the ongoing care and evaluation of pulmonary arterial hypertension patients with “exposure risk” to COVID-19 for patients coming to clinic or the hospital. If there is a morbidity and mortality benefit from starting pulmonary arterial hypertension therapies, for example in a patient with high-likelihood of pulmonary arterial hypertension, then it remains important to complete the thorough evaluation. However, the COVID-19 outbreak may also represent a unique time when pulmonary hypertension experts have to weigh the risks and benefits of the diagnostic work-up including potential exposure to COVID-19 versus initiating targeted pulmonary arterial hypertension therapy in a select high-risk, high likelihood World Symposium Pulmonary Hypertension Group 1 pulmonary arterial hypertension patients. This document will highlight some of the issues facing providers, patients, and the pulmonary arterial hypertension community in real-time as the COVID-19 pandemic is evolving and is intended to share expected common clinical scenarios and best clinical practices to help the community at-large. |
url |
https://doi.org/10.1177/2045894020920153 |
work_keys_str_mv |
AT johnjryan careofpatientswithpulmonaryarterialhypertensionduringthecoronaviruscovid19pandemic AT lanamelendresgroves careofpatientswithpulmonaryarterialhypertensionduringthecoronaviruscovid19pandemic AT rohamtzamanian careofpatientswithpulmonaryarterialhypertensionduringthecoronaviruscovid19pandemic AT ronaldjoudiz careofpatientswithpulmonaryarterialhypertensionduringthecoronaviruscovid19pandemic AT muralichakinala careofpatientswithpulmonaryarterialhypertensionduringthecoronaviruscovid19pandemic AT erikabrosenzweig careofpatientswithpulmonaryarterialhypertensionduringthecoronaviruscovid19pandemic AT mardigombergmaitland careofpatientswithpulmonaryarterialhypertensionduringthecoronaviruscovid19pandemic |
_version_ |
1724554718068342784 |